MCGREVIN GENE R 13D/13G Filings for TriSalus Life Sciences, Inc. (TLSI)

MCGREVIN GENE R 13D and 13G filings for TriSalus Life Sciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-08-21
4:36 pm
Purchase
2023-08-1013GTriSalus Life Sciences, Inc.
TLSI
MCGREVIN GENE R1,403,130
5.300%
1,403,130increase
(New Position)
Filing